Strategic market intelligence from Western Market Research indicates that the Global Urolithiasis Management Devices Market was valued at approximately USD 5.82 billion in 2025 and is projected to reach a valuation of USD 10.95 billion by the year 2036, expanding at a compound annual growth rate (CAGR) of 5.9% during the forecast period.
Global Urolithiasis Management Devices Market Overview
The 2025 Global Urolithiasis Management Devices report provides a forensic analysis of the clinical technologies used to treat urinary calculi (kidney, bladder, and ureter stones). This research tracks the industry’s transition from invasive open surgeries to minimally invasive (MIS) and non-invasive procedures. Utilizing a combination of primary clinical data and secondary financial modeling, the report forecasts a decade of growth driven by high-power laser systems, disposable endoscopes, and the globalization of specialized urology clinics.
The Post-Pandemic Clinical Environment
The 2020 COVID-19 outbreak caused a significant contraction in the urolithiasis market as kidney stone procedures were classified as "elective" or "non-urgent" in many jurisdictions. However, the subsequent "backlog surge" in 2022–2024 and a permanent shift toward Ambulatory Surgical Centers (ASCs) have reshaped the market. Post-pandemic growth is characterized by the rapid adoption of single-use ureteroscopes to eliminate the risk of cross-contamination and the utilization of telemedicine for post-operative stone management.
Global Urolithiasis Management Devices Market Segmentation
By Technology Type:
-
Extracorporeal Shock Wave Lithotripsy (ESWL): Non-invasive stone fragmentation using acoustic pulses.
-
Intracorporeal Lithotripsy: Includes Holmium:YAG and Thulium Fiber Lasers (TFL), Ultrasonic, and Pneumatic fragmentation.
-
Percutaneous Nephrolithotomy (PCNL): Devices used for the management of large or staghorn calculi via a small incision.
-
Ureteroscopy (URS): Flexible and semi-rigid endoscopes used for direct visual stone removal.
By Component & Consumables (New Segment):
-
Lithotripters: The capital equipment used for fragmentation.
-
Stone Retrieval Baskets: Nitinol-based tools for grasping and removing stone fragments.
-
Ureteral Stents: Temporary tubes to ensure drainage post-procedure.
-
Guidewires & Catheters: Essential navigational tools for endoscopic access.
By Application/End-User:
-
Hospitals & Tertiary Care Centers: Handling high-complexity PCNL and high-volume ESWL.
-
Ambulatory Surgical Centers (ASCs): The fastest-growing segment due to the shift toward outpatient ureteroscopy.
-
Specialty Urology Clinics: Focused on diagnostic screening and follow-up care.
Regional Analysis
-
North America: Leads the market share (~40%) due to high obesity and diabetes rates (key risk factors), a well-established reimbursement framework, and rapid adoption of Thulium Fiber Laser (TFL) technology.
-
Europe: A mature market driven by advanced R&D in Germany and France, with a heavy clinical preference for ESWL and flexible ureteroscopy.
-
Asia-Pacific: Anticipated to be the fastest-growing region through 2036. Drivers include the "Stone Belt" geography (high incidence in India and Southeast Asia), improving healthcare access, and rising medical tourism for affordable urological care.
-
LAMEA: Gradual growth supported by the modernization of surgical centers in the Middle East and Brazil.
Top Key Players
-
Global Market Dominators: Boston Scientific Corporation, Olympus Corporation, Cook Medical, C.R. Bard (Becton, Dickinson and Company).
-
Imaging & Capital Equipment: Siemens Healthineers, Richard Wolf GmbH, Karl Storz, Dornier MedTech, Philips Healthcare.
-
Specialized Lithotripsy & Laser: Lumenis (Boston Scientific), EDAP TMS, DirexGroup, Guangzhou Potent Optotronic, HealthTronics, Inc.
-
Consumable Specialists: Coloplast A/S, Teleflex Incorporated, ConMed Corporation, Medtronic (Urological Division).
Porter’s Five Forces Analysis
-
Threat of New Entrants (Low): High R&D costs for laser and imaging technology, coupled with stringent FDA/CE Class III regulations, create significant barriers.
-
Bargaining Power of Buyers (High): Hospital GPOs (Group Purchasing Organizations) and large ASC chains exert massive pressure on the pricing of consumables like stents and guidewires.
-
Bargaining Power of Suppliers (Moderate): Suppliers of high-purity nitinol and specialized fiber optics hold steady power.
-
Threat of Substitutes (Low): Medical Expulsive Therapy (MET) drugs are only effective for very small stones; mechanical or laser intervention remains essential for larger calculi.
-
Competitive Rivalry (Intense): Intense competition between Boston Scientific and Olympus to capture the "Single-Use Endoscope" market.
SWOT Analysis
-
Strengths: High procedural success rates; shift toward minimally invasive techniques reducing hospital stay duration.
-
Weaknesses: High cost of advanced laser systems; potential for post-operative infections and ureteral injury.
-
Opportunities: The rise of Disposable Ureteroscopes; integration of AI-driven stone analysis during surgery; expansion into emerging economies.
-
Threats: Reimbursement cuts for outpatient procedures; increasing cost of raw surgical-grade materials.
Trend Analysis
-
The "Thulium Fiber Laser" (TFL) Revolution: TFL is rapidly replacing Holmium:YAG as the preferred laser due to finer dusting capabilities and faster procedural times.
-
Single-Use Ureteroscopy: A massive move toward disposable scopes to eliminate reprocessing costs and sterilization failures.
-
Mini-PCNL: The development of ultra-thin instruments that allow PCNL procedures to be performed with less trauma, bridging the gap between URS and traditional PCNL.
Drivers & Challenges
-
Driver: Rising global prevalence of obesity, dehydration, and high-sodium diets, leading to a higher incidence of urolithiasis.
-
Driver: Technological advancements in "Stone Dusting" techniques that reduce the need for physical retrieval.
-
Challenge: The risk of sepsis and ureteral strictures following complex endoscopic procedures.
-
Challenge: Limited healthcare budgets in developing regions, making advanced laser therapy inaccessible for large populations.
Value Chain Analysis
-
R&D: Focusing on laser physics, optics, and biometric stone tracking.
-
Manufacturing: High-precision assembly of laser fibers and nitinol baskets in ISO cleanrooms.
-
Regulatory Clearance: Navigating complex PMA and MDR pathways for invasive devices.
-
Distribution: Leveraging specialized urological distributors and hospital-direct sales teams.
-
Post-Market Support: Surgeon training (Proctoring) and device maintenance for capital equipment.
Quick Recommendations for Stakeholders
-
For Manufacturers: Prioritize the development of Integrated AI software that can automatically predict stone composition and recommend optimal laser settings.
-
For Investors: Focus on the Consumables and Disposable Scope segments; while capital equipment has high margins, disposables provide stable, recurring revenue streams.
-
For Hospitals: Invest in Thulium Fiber Lasers to increase theatre efficiency and reduce "retreatment" rates, which are critical for value-based care metrics.
-
For R&D Teams: Develop Bioresorbable Stents that dissolve naturally, eliminating the need for a secondary procedure to remove the stent, thereby significantly improving patient satisfaction.
1. Market Overview of Urolithiasis Management Devices
1.1 Urolithiasis Management Devices Market Overview
1.1.1 Urolithiasis Management Devices Product Scope
1.1.2 Market Status and Outlook
1.2 Urolithiasis Management Devices Market Size by Regions:
1.3 Urolithiasis Management Devices Historic Market Size by Regions
1.4 Urolithiasis Management Devices Forecasted Market Size by Regions
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Urolithiasis Management Devices Sales Market by Type
2.1 Global Urolithiasis Management Devices Historic Market Size by Type
2.2 Global Urolithiasis Management Devices Forecasted Market Size by Type
2.3 Extracorporeal Shock Wave Lithotripsy (Eswl)
2.4 Intracorporeal Lithotripsy
2.5 Percutaneous Nephrolithotomy
2.6 Other Treatments
3. Covid-19 Impact Urolithiasis Management Devices Sales Market by Application
3.1 Global Urolithiasis Management Devices Historic Market Size by Application
3.2 Global Urolithiasis Management Devices Forecasted Market Size by Application
3.3 Hospitals & Clinics
3.4 Ambulatory Surgical Centers
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Urolithiasis Management Devices Production Capacity Market Share by Manufacturers
4.2 Global Urolithiasis Management Devices Revenue Market Share by Manufacturers
4.3 Global Urolithiasis Management Devices Average Price by Manufacturers
5. Company Profiles and Key Figures in Urolithiasis Management Devices Business
5.1 Allengers Medical Systems Ltd.
5.1.1 Allengers Medical Systems Ltd. Company Profile
5.1.2 Allengers Medical Systems Ltd. Urolithiasis Management Devices Product Specification
5.1.3 Allengers Medical Systems Ltd. Urolithiasis Management Devices Production Capacity, Revenue, Price and Gross Margin
5.2 Boston Scientific Corporation
5.2.1 Boston Scientific Corporation Company Profile
5.2.2 Boston Scientific Corporation Urolithiasis Management Devices Product Specification
5.2.3 Boston Scientific Corporation Urolithiasis Management Devices Production Capacity, Revenue, Price and Gross Margin
5.3 C.R. Bard Inc.
5.3.1 C.R. Bard Inc. Company Profile
5.3.2 C.R. Bard Inc. Urolithiasis Management Devices Product Specification
5.3.3 C.R. Bard Inc. Urolithiasis Management Devices Production Capacity, Revenue, Price and Gross Margin
5.4 Cook Medical
5.4.1 Cook Medical Company Profile
5.4.2 Cook Medical Urolithiasis Management Devices Product Specification
5.4.3 Cook Medical Urolithiasis Management Devices Production Capacity, Revenue, Price and Gross Margin
5.5 ConMed Corporation
5.5.1 ConMed Corporation Company Profile
5.5.2 ConMed Corporation Urolithiasis Management Devices Product Specification
5.5.3 ConMed Corporation Urolithiasis Management Devices Production Capacity, Revenue, Price and Gross Margin
5.6 DirexGroup
5.6.1 DirexGroup Company Profile
5.6.2 DirexGroup Urolithiasis Management Devices Product Specification
5.6.3 DirexGroup Urolithiasis Management Devices Production Capacity, Revenue, Price and Gross Margin
5.7 Dornier MedTech GmbH
5.7.1 Dornier MedTech GmbH Company Profile
5.7.2 Dornier MedTech GmbH Urolithiasis Management Devices Product Specification
5.7.3 Dornier MedTech GmbH Urolithiasis Management Devices Production Capacity, Revenue, Price and Gross Margin
5.8 Guangzhou Potent Optotronic Technology Co. Ltd.
5.8.1 Guangzhou Potent Optotronic Technology Co. Ltd. Company Profile
5.8.2 Guangzhou Potent Optotronic Technology Co. Ltd. Urolithiasis Management Devices Product Specification
5.8.3 Guangzhou Potent Optotronic Technology Co. Ltd. Urolithiasis Management Devices Production Capacity, Revenue, Price and Gross Margin
5.9 HealthTronics Inc.
5.9.1 HealthTronics Inc. Company Profile
5.9.2 HealthTronics Inc. Urolithiasis Management Devices Product Specification
5.9.3 HealthTronics Inc. Urolithiasis Management Devices Production Capacity, Revenue, Price and Gross Margin
5.10 Karl Storz GmbH & Co. KG
5.10.1 Karl Storz GmbH & Co. KG Company Profile
5.10.2 Karl Storz GmbH & Co. KG Urolithiasis Management Devices Product Specification
5.10.3 Karl Storz GmbH & Co. KG Urolithiasis Management Devices Production Capacity, Revenue, Price and Gross Margin
5.11 Lumenis
5.11.1 Lumenis Company Profile
5.11.2 Lumenis Urolithiasis Management Devices Product Specification
5.11.3 Lumenis Urolithiasis Management Devices Production Capacity, Revenue, Price and Gross Margin
5.12 Olympus Corporation
5.12.1 Olympus Corporation Company Profile
5.12.2 Olympus Corporation Urolithiasis Management Devices Product Specification
5.12.3 Olympus Corporation Urolithiasis Management Devices Production Capacity, Revenue, Price and Gross Margin
5.13 Richard Wolf
5.13.1 Richard Wolf Company Profile
5.13.2 Richard Wolf Urolithiasis Management Devices Product Specification
5.13.3 Richard Wolf Urolithiasis Management Devices Production Capacity, Revenue, Price and Gross Margin
5.14 Siemens Healthcare
5.14.1 Siemens Healthcare Company Profile
5.14.2 Siemens Healthcare Urolithiasis Management Devices Product Specification
5.14.3 Siemens Healthcare Urolithiasis Management Devices Production Capacity, Revenue, Price and Gross Margin
6. North America
6.1 North America Urolithiasis Management Devices Market Size
6.2 North America Urolithiasis Management Devices Key Players in North America
6.3 North America Urolithiasis Management Devices Market Size by Type
6.4 North America Urolithiasis Management Devices Market Size by Application
7. East Asia
7.1 East Asia Urolithiasis Management Devices Market Size
7.2 East Asia Urolithiasis Management Devices Key Players in North America
7.3 East Asia Urolithiasis Management Devices Market Size by Type
7.4 East Asia Urolithiasis Management Devices Market Size by Application
8. Europe
8.1 Europe Urolithiasis Management Devices Market Size
8.2 Europe Urolithiasis Management Devices Key Players in North America
8.3 Europe Urolithiasis Management Devices Market Size by Type
8.4 Europe Urolithiasis Management Devices Market Size by Application
9. South Asia
9.1 South Asia Urolithiasis Management Devices Market Size
9.2 South Asia Urolithiasis Management Devices Key Players in North America
9.3 South Asia Urolithiasis Management Devices Market Size by Type
9.4 South Asia Urolithiasis Management Devices Market Size by Application
10. Southeast Asia
10.1 Southeast Asia Urolithiasis Management Devices Market Size
10.2 Southeast Asia Urolithiasis Management Devices Key Players in North America
10.3 Southeast Asia Urolithiasis Management Devices Market Size by Type
10.4 Southeast Asia Urolithiasis Management Devices Market Size by Application
11. Middle East
11.1 Middle East Urolithiasis Management Devices Market Size
11.2 Middle East Urolithiasis Management Devices Key Players in North America
11.3 Middle East Urolithiasis Management Devices Market Size by Type
11.4 Middle East Urolithiasis Management Devices Market Size by Application
12. Africa
12.1 Africa Urolithiasis Management Devices Market Size
12.2 Africa Urolithiasis Management Devices Key Players in North America
12.3 Africa Urolithiasis Management Devices Market Size by Type
12.4 Africa Urolithiasis Management Devices Market Size by Application
13. Oceania
13.1 Oceania Urolithiasis Management Devices Market Size
13.2 Oceania Urolithiasis Management Devices Key Players in North America
13.3 Oceania Urolithiasis Management Devices Market Size by Type
13.4 Oceania Urolithiasis Management Devices Market Size by Application
14. South America
14.1 South America Urolithiasis Management Devices Market Size
14.2 South America Urolithiasis Management Devices Key Players in North America
14.3 South America Urolithiasis Management Devices Market Size by Type
14.4 South America Urolithiasis Management Devices Market Size by Application
15. Rest of the World
15.1 Rest of the World Urolithiasis Management Devices Market Size
15.2 Rest of the World Urolithiasis Management Devices Key Players in North America
15.3 Rest of the World Urolithiasis Management Devices Market Size by Type
15.4 Rest of the World Urolithiasis Management Devices Market Size by Application
16 Urolithiasis Management Devices Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Global Urolithiasis Management Devices Market Segmentation
By Technology Type:
-
Extracorporeal Shock Wave Lithotripsy (ESWL): Non-invasive stone fragmentation using acoustic pulses.
-
Intracorporeal Lithotripsy: Includes Holmium:YAG and Thulium Fiber Lasers (TFL), Ultrasonic, and Pneumatic fragmentation.
-
Percutaneous Nephrolithotomy (PCNL): Devices used for the management of large or staghorn calculi via a small incision.
-
Ureteroscopy (URS): Flexible and semi-rigid endoscopes used for direct visual stone removal.
By Component & Consumables (New Segment):
-
Lithotripters: The capital equipment used for fragmentation.
-
Stone Retrieval Baskets: Nitinol-based tools for grasping and removing stone fragments.
-
Ureteral Stents: Temporary tubes to ensure drainage post-procedure.
-
Guidewires & Catheters: Essential navigational tools for endoscopic access.
By Application/End-User:
-
Hospitals & Tertiary Care Centers: Handling high-complexity PCNL and high-volume ESWL.
-
Ambulatory Surgical Centers (ASCs): The fastest-growing segment due to the shift toward outpatient ureteroscopy.
-
Specialty Urology Clinics: Focused on diagnostic screening and follow-up care.
Regional Analysis
-
North America: Leads the market share (~40%) due to high obesity and diabetes rates (key risk factors), a well-established reimbursement framework, and rapid adoption of Thulium Fiber Laser (TFL) technology.
-
Europe: A mature market driven by advanced R&D in Germany and France, with a heavy clinical preference for ESWL and flexible ureteroscopy.
-
Asia-Pacific: Anticipated to be the fastest-growing region through 2036. Drivers include the "Stone Belt" geography (high incidence in India and Southeast Asia), improving healthcare access, and rising medical tourism for affordable urological care.
-
LAMEA: Gradual growth supported by the modernization of surgical centers in the Middle East and Brazil.
Top Key Players
-
Global Market Dominators: Boston Scientific Corporation, Olympus Corporation, Cook Medical, C.R. Bard (Becton, Dickinson and Company).
-
Imaging & Capital Equipment: Siemens Healthineers, Richard Wolf GmbH, Karl Storz, Dornier MedTech, Philips Healthcare.
-
Specialized Lithotripsy & Laser: Lumenis (Boston Scientific), EDAP TMS, DirexGroup, Guangzhou Potent Optotronic, HealthTronics, Inc.
-
Consumable Specialists: Coloplast A/S, Teleflex Incorporated, ConMed Corporation, Medtronic (Urological Division).
